Diversified Pharmaceutical Services, Inc. – Trademark Portfolio
Entity Type: 03
Diversified Pharmaceutical Services, Inc. holds 77 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 57 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. The owner is based in Edina, MN.
7760 France Avenue South, Suite 500
Edina, MN 55435
Showing of trademarks Trademarks
Trademark Classifications
Diversified Pharmaceutical Services, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Diversified Pharmaceutical Services, Inc. have?
Diversified Pharmaceutical Services, Inc. has 77 U.S. trademarks filed with the USPTO.
What trademark classes does Diversified Pharmaceutical Services, Inc. file in?
Diversified Pharmaceutical Services, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 16 (Paper Goods), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What is Diversified Pharmaceutical Services, Inc.'s trademark registration success rate?
Diversified Pharmaceutical Services, Inc. has a 0% trademark registration rate, with 0 out of 77 resolved applications resulting in successful registration. Currently, 0 applications are pending review.